{"id":6859,"date":"2025-10-14T12:40:33","date_gmt":"2025-10-14T10:40:33","guid":{"rendered":"https:\/\/cancer.itk.ee\/?p=6859"},"modified":"2025-12-02T13:23:16","modified_gmt":"2025-12-02T11:23:16","slug":"test","status":"publish","type":"post","link":"https:\/\/cancer.itk.ee\/ru\/2025\/10\/14\/test\/","title":{"rendered":"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel"},"content":{"rendered":"

Ida-Tallinna Keskhaigla osaleb uues rakendusuuringus, mis toob rinnav\u00e4hi ennetuse k\u00fcmme aastat varem nende naisteni, kelle geenid viitavad suuremale haigestumisriskile. Uuringus kutsutakse juhuvalimi alusel osalema 40-aastaseid naisi, kellele saadetakse kutse riigiportaali eesti.ee kaudu.<\/p>\n\n\n\n

Eesti v\u00e4hit\u00f5rje v\u00f5rgustik koost\u00f6\u00f6s Tervisekassa, Tartu \u00dclikooli, Ida-Tallinna Keskhaigla ja veel nelja keskusega alustas septembris kliinilist rakendusuuringut, mis p\u00f5hineb inimese geeniandmetel ehk pol\u00fcgeensel riskiskooril (PRS). Tegemist on Eestis ainulaadse rinnav\u00e4hi ennetusprojektiga, mille eesm\u00e4rk on tuvastada suurema geneetilise riskiga naised juba enne tavap\u00e4rast s\u00f5eluuringuiga.<\/p>\n\n\n\n

Uuring annab v\u00f5imaluse osaleda rinnav\u00e4hi s\u00f5eluuringus k\u00fcmme aastat varem kui seni \u2013 enne 50. eluaastat. Osalejad saavad teada, kas neil esineb k\u00f5rgem geneetiline risk rinnav\u00e4hki haigestuda, ning vajadusel j\u00e4\u00e4vad nad varajasele j\u00e4lgimisele.<\/p>\n\n\n\n

Kutsed uuringus osalemiseks saadetakse juhuvalimi alusel 40-aastastele naistele eesti.ee riigiportaali kaudu. Soovitatav on kontrollida, et portaali teavitused oleks suunatud oma igap\u00e4evaselt kasutatavale e-posti aadressile.<\/p>\n\n\n\n

Kutsele vastates saab broneerida aja rinnakabinetti n\u00f5ustamiseks l\u00e4himas uuringukeskuses. Rakendusuuringus osalevad Ida-Tallinna Keskhaigla, Tartu \u00dclikooli Kliinikum, P\u00f5hja-Eesti Regionaalhaigla, P\u00e4rnu Haigla ja Ida-Viru Keskhaigla.<\/p>\n\n\n\n

Rinnakabinetis k\u00fcsitleb osalejat \u00e4mmaemand ning v\u00f5etakse veeniveri, mille p\u00f5hjal m\u00e4\u00e4ratakse geneetiline riskiskoor.<\/p>\n\n\n\n

Kui risk on madal, j\u00e4tkub j\u00e4lgimine alates 50. eluaastast riikliku s\u00f5eluuringu raames.<\/p>\n\n\n\n

Kui risk on k\u00f5rgenenud, v\u00f5etakse osalejaga \u00fchendust ja m\u00e4\u00e4ratakse mammograafia aeg; edaspidi soovitatakse kordusuuringut kahe aasta p\u00e4rast.<\/p>\n\n\n\n

K\u00f5igil osalejatel on v\u00f5imalik saada p\u00e4rast testi tegemist n\u00f5ustamist ka telefoni teel.<\/p>\n\n\n\n

Lisainfo: https:\/\/tervisekassa.ee\/prs-soeluuring<\/p>","protected":false},"excerpt":{"rendered":"

Ida-Tallinna Keskhaigla osaleb uues rakendusuuringus, mis toob rinnav\u00e4hi ennetuse k\u00fcmme aastat varem nende naisteni, kelle geenid viitavad suuremale haigestumisriskile. Uuringus kutsutakse juhuvalimi alusel osalema 40-aastaseid naisi, kellele saadetakse kutse riigiportaali eesti.ee kaudu. Eesti v\u00e4hit\u00f5rje v\u00f5rgustik koost\u00f6\u00f6s Tervisekassa, Tartu \u00dclikooli, Ida-Tallinna Keskhaigla ja veel nelja keskusega alustas septembris kliinilist rakendusuuringut, mis p\u00f5hineb inimese geeniandmetel ehk pol\u00fcgeensel […]<\/p>\n","protected":false},"author":7,"featured_media":6862,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"cybocfi_hide_featured_image":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-6859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spetsialistide-kogemused"],"aioseo_notices":[],"yoast_head":"\n40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel - Ida-Tallinna Keskhaigla<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"ru_RU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel - Ida-Tallinna Keskhaigla\" \/>\n<meta property=\"og:description\" content=\"Ida-Tallinna Keskhaigla osaleb uues rakendusuuringus, mis toob rinnav\u00e4hi ennetuse k\u00fcmme aastat varem nende naisteni, kelle geenid viitavad suuremale haigestumisriskile. Uuringus kutsutakse juhuvalimi alusel osalema 40-aastaseid naisi, kellele saadetakse kutse riigiportaali eesti.ee kaudu. Eesti v\u00e4hit\u00f5rje v\u00f5rgustik koost\u00f6\u00f6s Tervisekassa, Tartu \u00dclikooli, Ida-Tallinna Keskhaigla ja veel nelja keskusega alustas septembris kliinilist rakendusuuringut, mis p\u00f5hineb inimese geeniandmetel ehk pol\u00fcgeensel […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cancer.itk.ee\/ru\/2025\/10\/14\/test\/\" \/>\n<meta property=\"og:site_name\" content=\"Ida-Tallinna Keskhaigla\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Keskhaigla\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-14T10:40:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-02T11:23:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2025\/12\/Capture.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"393\" \/>\n\t<meta property=\"og:image:height\" content=\"281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marek Simulman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marek Simulman\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u043c\u0438\u043d\u0443\u0442\u044b\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/\"},\"author\":{\"name\":\"Marek Simulman\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#\\\/schema\\\/person\\\/14c2453373c54ceca8e303c7c89035d5\"},\"headline\":\"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel\",\"datePublished\":\"2025-10-14T10:40:33+00:00\",\"dateModified\":\"2025-12-02T11:23:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/\"},\"wordCount\":262,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cancer.itk.ee\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Capture.jpg\",\"articleSection\":[\"Spetsialistide kogemused\"],\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/\",\"url\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/\",\"name\":\"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel - Ida-Tallinna Keskhaigla\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cancer.itk.ee\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Capture.jpg\",\"datePublished\":\"2025-10-14T10:40:33+00:00\",\"dateModified\":\"2025-12-02T11:23:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#breadcrumb\"},\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cancer.itk.ee\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Capture.jpg\",\"contentUrl\":\"https:\\\/\\\/cancer.itk.ee\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Capture.jpg\",\"width\":393,\"height\":281},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/2025\\\/10\\\/14\\\/test\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Avaleht\",\"item\":\"https:\\\/\\\/cancer.itk.ee\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#website\",\"url\":\"https:\\\/\\\/cancer.itk.ee\\\/\",\"name\":\"Ida-Tallinna Keskhaigla\",\"description\":\"V\u00e4hiravi\",\"publisher\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cancer.itk.ee\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ru-RU\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#organization\",\"name\":\"Ida-Tallinna Keskhaigla\",\"url\":\"https:\\\/\\\/cancer.itk.ee\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cancer.itk.ee\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/cropped-itk-logo-right.png\",\"contentUrl\":\"https:\\\/\\\/cancer.itk.ee\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/cropped-itk-logo-right.png\",\"width\":400,\"height\":173,\"caption\":\"Ida-Tallinna Keskhaigla\"},\"image\":{\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Keskhaigla\",\"https:\\\/\\\/www.instagram.com\\\/keskhaiglasunnitusmaja\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCA3iAAYkT6GAo0d9egRYSrQ\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cancer.itk.ee\\\/#\\\/schema\\\/person\\\/14c2453373c54ceca8e303c7c89035d5\",\"name\":\"Marek Simulman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/da20184f6ca605c16dc7c4e1511a74c95ec20df9e5d02d85364cc0ea05f9c1d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/da20184f6ca605c16dc7c4e1511a74c95ec20df9e5d02d85364cc0ea05f9c1d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/da20184f6ca605c16dc7c4e1511a74c95ec20df9e5d02d85364cc0ea05f9c1d2?s=96&d=mm&r=g\",\"caption\":\"Marek Simulman\"},\"url\":false}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel - Ida-Tallinna Keskhaigla","robots":{"index":"noindex","follow":"follow"},"og_locale":"ru_RU","og_type":"article","og_title":"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel - Ida-Tallinna Keskhaigla","og_description":"Ida-Tallinna Keskhaigla osaleb uues rakendusuuringus, mis toob rinnav\u00e4hi ennetuse k\u00fcmme aastat varem nende naisteni, kelle geenid viitavad suuremale haigestumisriskile. Uuringus kutsutakse juhuvalimi alusel osalema 40-aastaseid naisi, kellele saadetakse kutse riigiportaali eesti.ee kaudu. Eesti v\u00e4hit\u00f5rje v\u00f5rgustik koost\u00f6\u00f6s Tervisekassa, Tartu \u00dclikooli, Ida-Tallinna Keskhaigla ja veel nelja keskusega alustas septembris kliinilist rakendusuuringut, mis p\u00f5hineb inimese geeniandmetel ehk pol\u00fcgeensel […]","og_url":"https:\/\/cancer.itk.ee\/ru\/2025\/10\/14\/test\/","og_site_name":"Ida-Tallinna Keskhaigla","article_publisher":"https:\/\/www.facebook.com\/Keskhaigla","article_published_time":"2025-10-14T10:40:33+00:00","article_modified_time":"2025-12-02T11:23:16+00:00","og_image":[{"width":393,"height":281,"url":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2025\/12\/Capture.jpg","type":"image\/jpeg"}],"author":"Marek Simulman","twitter_card":"summary_large_image","twitter_misc":{"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c":"Marek Simulman","\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f":"2 \u043c\u0438\u043d\u0443\u0442\u044b"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#article","isPartOf":{"@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/"},"author":{"name":"Marek Simulman","@id":"https:\/\/cancer.itk.ee\/#\/schema\/person\/14c2453373c54ceca8e303c7c89035d5"},"headline":"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel","datePublished":"2025-10-14T10:40:33+00:00","dateModified":"2025-12-02T11:23:16+00:00","mainEntityOfPage":{"@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/"},"wordCount":262,"commentCount":0,"publisher":{"@id":"https:\/\/cancer.itk.ee\/#organization"},"image":{"@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#primaryimage"},"thumbnailUrl":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2025\/12\/Capture.jpg","articleSection":["Spetsialistide kogemused"],"inLanguage":"ru-RU","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/","url":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/","name":"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel - Ida-Tallinna Keskhaigla","isPartOf":{"@id":"https:\/\/cancer.itk.ee\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#primaryimage"},"image":{"@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#primaryimage"},"thumbnailUrl":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2025\/12\/Capture.jpg","datePublished":"2025-10-14T10:40:33+00:00","dateModified":"2025-12-02T11:23:16+00:00","breadcrumb":{"@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#breadcrumb"},"inLanguage":"ru-RU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/"]}]},{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#primaryimage","url":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2025\/12\/Capture.jpg","contentUrl":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2025\/12\/Capture.jpg","width":393,"height":281},{"@type":"BreadcrumbList","@id":"https:\/\/cancer.itk.ee\/2025\/10\/14\/test\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Avaleht","item":"https:\/\/cancer.itk.ee\/"},{"@type":"ListItem","position":2,"name":"40-aastased naised saavad esmakordselt rinnav\u00e4hi s\u00f5eluuringule geneetilise riski alusel"}]},{"@type":"WebSite","@id":"https:\/\/cancer.itk.ee\/#website","url":"https:\/\/cancer.itk.ee\/","name":"Ida-Tallinna Keskhaigla","description":"\u041b\u0435\u0447\u0435\u043d\u0438\u0435 \u0440\u0430\u043a\u0430","publisher":{"@id":"https:\/\/cancer.itk.ee\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cancer.itk.ee\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ru-RU"},{"@type":"Organization","@id":"https:\/\/cancer.itk.ee\/#organization","name":"Ida-Tallinna Keskhaigla","url":"https:\/\/cancer.itk.ee\/","logo":{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/cancer.itk.ee\/#\/schema\/logo\/image\/","url":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2021\/03\/cropped-itk-logo-right.png","contentUrl":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2021\/03\/cropped-itk-logo-right.png","width":400,"height":173,"caption":"Ida-Tallinna Keskhaigla"},"image":{"@id":"https:\/\/cancer.itk.ee\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Keskhaigla","https:\/\/www.instagram.com\/keskhaiglasunnitusmaja\/","https:\/\/www.youtube.com\/channel\/UCA3iAAYkT6GAo0d9egRYSrQ"]},{"@type":"Person","@id":"https:\/\/cancer.itk.ee\/#\/schema\/person\/14c2453373c54ceca8e303c7c89035d5","name":"Marek Simulman","image":{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/secure.gravatar.com\/avatar\/da20184f6ca605c16dc7c4e1511a74c95ec20df9e5d02d85364cc0ea05f9c1d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/da20184f6ca605c16dc7c4e1511a74c95ec20df9e5d02d85364cc0ea05f9c1d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/da20184f6ca605c16dc7c4e1511a74c95ec20df9e5d02d85364cc0ea05f9c1d2?s=96&d=mm&r=g","caption":"Marek Simulman"},"url":false}]}},"_links":{"self":[{"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/posts\/6859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/comments?post=6859"}],"version-history":[{"count":2,"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/posts\/6859\/revisions"}],"predecessor-version":[{"id":6863,"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/posts\/6859\/revisions\/6863"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/media\/6862"}],"wp:attachment":[{"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/media?parent=6859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/categories?post=6859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancer.itk.ee\/ru\/wp-json\/wp\/v2\/tags?post=6859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}